Sign Out
Fertility: Latanoprost has not been found to have any effect on male or female fertility in animal studies.
Pregnancy: This product should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. (The safety of this product during pregnancy has not been established. Reproduction studies have been performed in rabbits. In the study of administration during organogenesis in rabbits, it has been shown that increased incidences of late resorption ad abortion and reduced fetal weight when given in intravenous doses approximately 100 times the recommended clinical dose [5.0 μg/kg/day]).
Lactation: Administration of this product should be avoided to a nursing woman. If treatment with this product becomes essential, breast feeding must be discontinued. (An animal study [in rats, i.v.] has shown that the drug was excreted in breast milk.)
